{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":104,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":104,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"cf2946318e0f","filters":{"venue":"PharmacoEconomics & Outcomes News"}},"results":[{"id":"W4232246152","doi":"10.1007/s40274-016-2750-9","title":"Analysing high-cost users of healthcare in Canada","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Business; Health care; Public health; Health administration; Computer science; Nursing; Medicine; Economics; Economic growth","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05158430184563264,"gpt":0.3235502121192386,"spread":0.271965910273606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004549159,0.0002186852,0.0008070503,0.0004047546,0.00004613024,0.00001770108,0.0003616519,0.00005318835,0.0004009138],"category_scores_gemma":[0.00005812293,0.000210971,0.000132136,0.0001979665,0.0000262322,0.00026216,0.00009942665,0.0001302759,0.0001388024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001960595,"about_ca_system_score_gemma":0.0004138103,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9860527,"about_ca_topic_score_gemma":0.973613,"domain_scores_codex":[0.9975107,0.00003911839,0.001381213,0.0004623441,0.00003952827,0.0005671461],"domain_scores_gemma":[0.9985803,0.0001628875,0.0005933545,0.000422106,0.00002147157,0.0002198454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002672618,0.00003763283,0.8777694,0.00008946218,0.0001210429,0.00000749637,0.0001375766,0.0002905252,0.00002182027,0.1002286,0.00332857,0.01794115],"study_design_scores_gemma":[0.004896775,0.00004506773,0.3835388,0.00007074871,0.00002595515,0.000002036565,0.0002850253,0.001053444,0.0008251046,0.01402657,0.5942637,0.0009667281],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7975903,0.000428281,0.000455142,0.1967209,0.001250394,0.0005382243,0.000740568,0.00002365212,0.002252537],"genre_scores_gemma":[0.9797786,0.0008716941,0.0002374856,0.0186444,0.00006709177,0.00003973307,0.000009838089,0.00003141364,0.0003197843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5909352,"threshold_uncertainty_score":0.8603148,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255482650","doi":"10.2165/00151234-201206490-00031","title":"Denosumab available for PMO in Ontario","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Denosumab; Quality of Life Research; Medicine; Business; Public health; Internal medicine; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.06464038649937859,"gpt":0.3762020785621502,"spread":0.3115616920627716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002026211,0.0001962213,0.0004772095,0.0001198742,0.00005661472,0.00001341064,0.00007168196,0.00007200627,0.001672582],"category_scores_gemma":[0.00001810843,0.0001783768,0.0001476622,0.00003770101,0.00001357565,0.0002301952,0.00002907186,0.0001979903,0.001367989],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000948447,"about_ca_system_score_gemma":0.0003478575,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05995612,"about_ca_topic_score_gemma":0.08395614,"domain_scores_codex":[0.998622,0.00001469634,0.0004294756,0.0002297936,0.00005365484,0.0006503754],"domain_scores_gemma":[0.9991354,0.0001119158,0.0001001188,0.0002271877,0.00001833198,0.0004070285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002705659,0.0003646263,0.9708757,0.00004018776,0.00009258784,0.00000351085,0.0003037732,0.000001967156,0.00004026632,0.0001312351,0.02475906,0.003116498],"study_design_scores_gemma":[0.009784306,0.00007701974,0.370674,0.000009964038,0.0001360177,0.00001913559,0.0000251069,0.00007941751,0.0006009626,0.0000758434,0.6183444,0.0001737385],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791488,0.0005345645,0.00001693504,0.00374559,0.001102326,0.001209261,0.00001727969,0.00004372177,0.01418154],"genre_scores_gemma":[0.9344966,0.0001230164,0.003328999,0.02460681,0.000133574,0.000288112,0.00007814368,0.00005293072,0.0368918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6002017,"threshold_uncertainty_score":0.9994096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212981773","doi":"10.2165/00151234-201106410-00034","title":"Healthcare spending to reach > $200 billion in 2011 in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Health economics; Health spending; Public health; Economics; Business; Medicine; Economic growth; Health insurance; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1102672397341309,"gpt":0.3291838321007124,"spread":0.2189165923665815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007912067,0.0002964249,0.0007702377,0.0008673274,0.00005812255,0.00003015872,0.0004851776,0.00007844294,0.001099361],"category_scores_gemma":[0.00003977287,0.0003694229,0.00009540701,0.0002599281,0.0000115066,0.0002991936,0.0001748047,0.0003242827,0.001161374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003000459,"about_ca_system_score_gemma":0.0002979169,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9923317,"about_ca_topic_score_gemma":0.9872532,"domain_scores_codex":[0.996867,0.00004994805,0.001462494,0.0006959547,0.0000407598,0.0008838487],"domain_scores_gemma":[0.9987622,0.00006717176,0.0003182628,0.0004553942,0.0000115033,0.0003854376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004070533,0.00006591748,0.925063,0.00006475313,0.00002653393,0.00003272254,0.001222204,0.0001408258,0.0000028127,0.06266996,0.005358366,0.00531222],"study_design_scores_gemma":[0.001738989,0.00005256264,0.6673359,0.00002899758,0.000004965026,0.000003297274,0.0005097536,0.001035811,0.0001015112,0.008935553,0.3194624,0.0007901807],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9212936,0.0006842259,0.00009134493,0.047973,0.002148395,0.001092294,0.0002281412,0.00003891939,0.02645006],"genre_scores_gemma":[0.9674393,0.0007752525,0.0006437733,0.03032123,0.00008952667,0.0001100522,0.00001531632,0.00004944036,0.0005561074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3141041,"threshold_uncertainty_score":0.9998758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249731256","doi":"10.1007/bf03276389","title":"Rx to non-Rx status switch recommended for emergency OC in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Medical emergency; Public health; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02815372646332114,"gpt":0.3439267633154504,"spread":0.3157730368521292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002737464,0.000382442,0.0009136296,0.000221263,0.00008551242,0.00001856978,0.000213664,0.00007019297,0.002537865],"category_scores_gemma":[0.0001455971,0.0003986707,0.0002115042,0.0002127423,0.000007847393,0.0001315938,0.00006169704,0.0002732626,0.0001362288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003036048,"about_ca_system_score_gemma":0.001855167,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6779819,"about_ca_topic_score_gemma":0.911522,"domain_scores_codex":[0.9973089,0.00004462439,0.0009362047,0.0005729671,0.0001327698,0.00100454],"domain_scores_gemma":[0.9984652,0.0001604388,0.0001813916,0.0004655856,0.00007160903,0.0006557244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001934075,0.0002426115,0.7749959,0.0001115974,0.0002614397,0.00001317171,0.0004815963,0.0001734376,0.002206856,0.0001569317,0.2118402,0.009322821],"study_design_scores_gemma":[0.01155295,0.0002896549,0.2084319,0.00003642763,0.0003027414,0.00002174614,0.0009644167,0.0009056991,0.01189713,0.0004215089,0.7640462,0.001129659],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9717995,0.0001058855,0.0001248315,0.01649362,0.002662086,0.002021896,0.0001609165,0.00003998129,0.006591276],"genre_scores_gemma":[0.960721,0.000342526,0.003982026,0.03229051,0.0001511148,0.0002710078,0.00006427825,0.0001221979,0.002055357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.566564,"threshold_uncertainty_score":0.9998465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236788575","doi":"10.2165/00151234-200605110-00006","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Atorvastatin; Ezetimibe; Quality of Life Research; Business; Public health; Medicine; Pharmacology; Statin; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0432454205352495,"gpt":0.3586166598155774,"spread":0.315371239280328,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003773145,0.0001989875,0.0005105273,0.0001153257,0.00004920555,0.00001976792,0.0001136052,0.00003750362,0.0001094331],"category_scores_gemma":[0.00006518225,0.0001881305,0.0002052655,0.00009716825,0.00000703048,0.00009969642,0.00002782335,0.0001480578,0.00004897036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001686073,"about_ca_system_score_gemma":0.001155948,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8040156,"about_ca_topic_score_gemma":0.7959099,"domain_scores_codex":[0.9984965,0.00003781881,0.0004997107,0.0003801542,0.0001787693,0.0004069867],"domain_scores_gemma":[0.9990863,0.0001879719,0.00009625708,0.0003572484,0.00004714847,0.0002251352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001739885,0.0002369208,0.5981115,0.0005970183,0.0002614709,0.00008077617,0.000158783,0.01375902,0.001145283,0.0009385091,0.2018484,0.1811225],"study_design_scores_gemma":[0.009240512,0.0003160674,0.5623506,0.0002440806,0.0001980512,0.00002555738,0.0002029831,0.003064502,0.005029025,0.0001503392,0.4184974,0.0006809625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796742,0.0003517611,0.0005045249,0.01608328,0.0006567697,0.00189705,0.00005486411,0.00002916618,0.0007483896],"genre_scores_gemma":[0.9547383,0.000142888,0.002480011,0.0412133,0.0005313449,0.000322566,0.00003438941,0.00004567123,0.000491508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.216649,"threshold_uncertainty_score":0.7671739,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230555985","doi":"10.2165/00151234-200605140-00024","title":"Isotretinoin use inappropriate in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Isotretinoin; Quality of Life Research; Medicine; Dermatology; Public health; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01338503712542532,"gpt":0.2821876621866829,"spread":0.2688026250612576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006338349,0.0002075479,0.0004316908,0.00008147002,0.00004293694,0.00002646723,0.00006945289,0.00004099929,0.0002129868],"category_scores_gemma":[0.000009492343,0.0001630737,0.00009597736,0.0000676418,0.00001275439,0.0001385401,0.00003719017,0.0001536703,0.00006644437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007263057,"about_ca_system_score_gemma":0.0005171371,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9551263,"about_ca_topic_score_gemma":0.8771597,"domain_scores_codex":[0.9989241,0.00002504876,0.0003619002,0.0002612742,0.00007478099,0.0003528506],"domain_scores_gemma":[0.999491,0.00008376216,0.0000877482,0.0001976779,0.00001420925,0.0001256173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008168442,0.000108927,0.9641645,0.00002414532,0.0000597385,0.000171699,0.00002424939,0.0002624945,0.0002662742,0.00007018789,0.03203353,0.002732583],"study_design_scores_gemma":[0.006687078,0.00004690437,0.8558129,0.00002240173,0.0001216376,0.00002864211,0.00006531332,0.002189291,0.002074495,0.00008620372,0.1325444,0.0003206844],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990095,0.0001460313,0.000008879082,0.00590218,0.0003887696,0.0003793688,0.00002476001,0.00002500192,0.003029994],"genre_scores_gemma":[0.9848611,0.0001280604,0.0002931508,0.01119547,0.0001232285,0.00002463677,0.0000592011,0.00002823697,0.003286917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1083516,"threshold_uncertainty_score":0.6649954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4229933154","doi":"10.2165/00151234-200705310-00009","title":"High intensity use of proton pump inhibitors (PPIs) increased between 1997 and 2004 in Canada,","year":2007,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Intensity (physics); Medicine; Public health; Optics; Physics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02376855002883469,"gpt":0.3031655579418374,"spread":0.2793970079130027,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002286636,0.0002517739,0.000767507,0.0001867947,0.000030722,0.00001281176,0.0000749275,0.00006133869,0.00004892723],"category_scores_gemma":[0.00005844242,0.0002226393,0.00007539101,0.00008768545,0.00004440621,0.000170294,0.00007336789,0.000233843,0.000008562113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008019748,"about_ca_system_score_gemma":0.000412633,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7924467,"about_ca_topic_score_gemma":0.3260093,"domain_scores_codex":[0.9984615,0.00002710547,0.0006758881,0.0003102487,0.0001310471,0.0003942354],"domain_scores_gemma":[0.9989529,0.0001985535,0.000216847,0.000222668,0.00004550357,0.0003635844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002101265,0.00008855852,0.9949897,0.00005908501,0.00017676,0.0002176921,0.00004945063,0.000007844284,0.0002411851,0.000006041692,0.0006477569,0.003305813],"study_design_scores_gemma":[0.00451513,0.00008423327,0.9583747,0.00002261783,0.0001463124,0.00001309738,0.00003227979,0.00003145179,0.0354398,0.00002058821,0.001217421,0.0001023236],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977947,0.00003535899,0.000006885649,0.0007178484,0.0002073203,0.001010953,0.0001573802,0.0000166346,0.00005295793],"genre_scores_gemma":[0.9964482,0.00003274597,0.0004527675,0.002736756,0.00008672081,0.00001813964,0.0001037557,0.0000278724,0.00009302371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4664375,"threshold_uncertainty_score":0.9078966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239255913","doi":"10.1007/bf03279550","title":"Methylphenidate use low but rising among children in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Methylphenidate; Quality of Life Research; Psychology; Public health; Medicine; Psychiatry; Attention deficit hyperactivity disorder","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03755825418251017,"gpt":0.3154979730792761,"spread":0.2779397188967659,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001250334,0.0003068927,0.0006496611,0.0001963234,0.00006815777,0.00006558916,0.0001677041,0.00006382631,0.001982514],"category_scores_gemma":[0.00009672314,0.0003170891,0.0001701124,0.0001420764,0.00003281366,0.0006067551,0.00008295729,0.0004659374,0.0002348306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009248246,"about_ca_system_score_gemma":0.0002198677,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8228482,"about_ca_topic_score_gemma":0.7428259,"domain_scores_codex":[0.998194,0.00007272119,0.0006060718,0.0004627036,0.0001663541,0.0004981267],"domain_scores_gemma":[0.9988707,0.0002130272,0.0002130682,0.0004103445,0.0000338187,0.0002590598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002268705,0.0001276915,0.989803,0.00001392085,0.0001643442,0.0000456231,0.00007827767,0.0007503375,0.0003549992,0.00001224338,0.004595752,0.004031171],"study_design_scores_gemma":[0.003893187,0.0000114918,0.9817866,0.00002204245,0.0001417916,0.00003791481,0.0002617191,0.01026576,0.0004478059,0.00001358267,0.002713038,0.000405062],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908659,0.000169252,0.00004440718,0.006887476,0.0004080869,0.0005795863,0.00005059938,0.00005364296,0.0009410607],"genre_scores_gemma":[0.9833153,0.0002572607,0.0002995831,0.01400781,0.00007814881,0.00002252766,0.00003611057,0.00006534105,0.001917927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08002234,"threshold_uncertainty_score":0.9999281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205687154","doi":"10.2165/00151234-200605110-00026","title":"Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect,","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Government (linguistics); Quality of Life Research; Drug; Public administration; Business; Law; Public health; Political science; Medicine; Pharmacology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05857380968842436,"gpt":0.3302997791268442,"spread":0.2717259694384199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003734202,0.0004135323,0.00131383,0.00006538189,0.0003708458,0.0001113419,0.001032705,0.00008484384,0.0000783189],"category_scores_gemma":[0.0002270533,0.0002825756,0.0002909472,0.0001432574,0.00006048126,0.0004049557,0.0001066539,0.0002969577,0.00002400438],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009761778,"about_ca_system_score_gemma":0.0009693821,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9864085,"about_ca_topic_score_gemma":0.9876821,"domain_scores_codex":[0.9938253,0.0004384551,0.004332202,0.0006453692,0.0001982634,0.0005604462],"domain_scores_gemma":[0.9929893,0.002857029,0.003063118,0.0009004067,0.00004066602,0.0001494759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005769637,0.00009693357,0.8750877,0.0001884777,0.0001780286,9.083623e-8,0.002346647,0.008227992,0.0000078045,0.0009159467,0.1123541,0.0005386543],"study_design_scores_gemma":[0.009692699,0.00008384066,0.5033603,0.0002222239,0.0001977465,0.000001105885,0.001917581,0.02508691,0.0003854378,0.002025647,0.4560085,0.001018039],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9344884,0.0008784123,0.0005655377,0.05455002,0.001951651,0.004784154,0.002362394,0.00001999894,0.0003994317],"genre_scores_gemma":[0.9898988,0.00002547331,0.0002130553,0.007448673,0.0002003425,0.0004826052,0.0001629702,0.00006230226,0.001505798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3717273,"threshold_uncertainty_score":0.9999626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4250881677","doi":"10.2165/00151234-200604990-00023","title":"Canadian generic market grows, but new drug access lags","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Drug; Business; Economics; Public health; Medicine; Pharmacology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04633601836258157,"gpt":0.3183512029349682,"spread":0.2720151845723866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005831466,0.0006132646,0.001132586,0.0007650822,0.0002754607,0.0006746858,0.00144842,0.0001814703,0.01017964],"category_scores_gemma":[0.00003928841,0.0007669296,0.0005069676,0.0002737073,0.00007038043,0.001065458,0.0002822471,0.0004527771,0.004451005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001125876,"about_ca_system_score_gemma":0.0004717675,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5754012,"about_ca_topic_score_gemma":0.1782768,"domain_scores_codex":[0.9958314,0.00003644435,0.001672306,0.001037854,0.00004274902,0.001379243],"domain_scores_gemma":[0.9972529,0.000154024,0.000623379,0.0007104153,0.0000271279,0.001232194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002490325,0.00007224162,0.175723,0.00002316108,0.0001799516,0.00001438197,0.00006253165,0.0005557984,0.00001958139,0.06177339,0.7592892,0.002261795],"study_design_scores_gemma":[0.001837082,0.000009268148,0.03257813,0.000003571653,0.00003745302,0.00001068432,0.0000142107,0.005413193,0.0002319699,0.04948328,0.9094504,0.0009307201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4629406,0.003997582,0.0002920209,0.1071378,0.004923614,0.00105416,0.00240604,0.0002525561,0.4169956],"genre_scores_gemma":[0.816578,0.002000114,0.0008967309,0.1178283,0.002422054,0.00009768167,0.000191141,0.0002450273,0.05974094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3971244,"threshold_uncertainty_score":0.9994782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230031586","doi":"10.1007/bf03267249","title":"Propentofylline worth it in Canada's AD population","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01827595898962494,"gpt":0.3298364210698375,"spread":0.3115604620802126,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001080903,0.0002189115,0.0004719122,0.00009327181,0.00005577402,0.00001128613,0.0001169742,0.00004879306,0.006876098],"category_scores_gemma":[0.0000069568,0.0001983539,0.00009117238,0.00008574485,0.00001368906,0.0001347604,0.0000235053,0.0002395426,0.0003082714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001357208,"about_ca_system_score_gemma":0.0005511599,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6284871,"about_ca_topic_score_gemma":0.8728157,"domain_scores_codex":[0.9986918,0.00004551751,0.0004853259,0.0003207107,0.0000944487,0.0003622038],"domain_scores_gemma":[0.9994317,0.00005306836,0.00008251678,0.0001974297,0.00001455759,0.0002207495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003518886,0.000252369,0.9365107,0.00002152196,0.0001364417,0.0001485218,0.00007018467,0.0005529246,0.00009892372,0.0000100876,0.01134627,0.0505001],"study_design_scores_gemma":[0.005596077,0.00003884063,0.8522332,0.00001561622,0.0001583952,0.0000260627,0.00002877821,0.00184354,0.0005383924,0.00003498112,0.1392659,0.0002201687],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9671202,0.0002153148,0.000001132869,0.02679597,0.0003161752,0.0006682345,0.00002427462,0.00003168576,0.004827044],"genre_scores_gemma":[0.9516799,0.0007280327,0.0001788997,0.04071745,0.00006948376,0.00005320127,0.0001232249,0.00002352587,0.006426222],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2443287,"threshold_uncertainty_score":0.9940317,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4238875952","doi":"10.1007/bf03276349","title":"Antibacterial use for outpatient CAP in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02982814105810694,"gpt":0.32263305937819,"spread":0.2928049183200831,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007206831,0.0002089023,0.0004494207,0.00007629146,0.00003547276,0.00002399636,0.00006428279,0.00003554282,0.0001938749],"category_scores_gemma":[0.00007155722,0.0001852436,0.0001162808,0.00003778181,0.000009611209,0.0001304041,0.00001594066,0.000105073,0.00002501274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009843748,"about_ca_system_score_gemma":0.0008032297,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3010542,"about_ca_topic_score_gemma":0.3915,"domain_scores_codex":[0.9988184,0.00002883483,0.0004064984,0.0002800848,0.00007187947,0.0003943102],"domain_scores_gemma":[0.9993364,0.0001167541,0.0001014325,0.0001993336,0.00002728279,0.0002188271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001197748,0.0001372624,0.9950628,0.00002217894,0.0001143387,0.00008406852,0.00004337259,0.00003822621,0.0002280474,0.00009176977,0.00269837,0.001359793],"study_design_scores_gemma":[0.02024288,0.000223534,0.8730637,0.00001380984,0.0002189154,0.0000221244,0.0000655677,0.0002737458,0.008204302,0.00006339773,0.09735176,0.0002563125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967661,0.00002460022,0.00001499848,0.0005294902,0.001305507,0.0008203052,0.0001219873,0.00001341763,0.0004035492],"genre_scores_gemma":[0.9912974,0.00003368665,0.001095722,0.006601412,0.00005277136,0.00006496711,0.00007197883,0.00003281033,0.0007491982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1219991,"threshold_uncertainty_score":0.7554016,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244986734","doi":"10.2165/00151234-200905850-00020","title":"Untreated maternal depression costly in Canada","year":2009,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Depression (economics); Psychiatry; Public health; Medicine; Psychology; Economics; Nursing; Keynesian economics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01562420561098424,"gpt":0.3283844411967805,"spread":0.3127602355857962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000752624,0.0001900021,0.0003854209,0.00008331552,0.00004136752,0.00001561947,0.0001198083,0.00003926031,0.0004424126],"category_scores_gemma":[0.000006114967,0.0001662005,0.00005560591,0.00004562264,0.000006780125,0.0001011203,0.00002549709,0.0002166027,0.00008044789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000848514,"about_ca_system_score_gemma":0.0003998023,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6950602,"about_ca_topic_score_gemma":0.4073206,"domain_scores_codex":[0.9987547,0.00003205201,0.0004710299,0.0002479199,0.0001032743,0.0003910659],"domain_scores_gemma":[0.9993661,0.00004246278,0.0001128857,0.0001895978,0.00001252793,0.0002764123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000468685,0.00004444481,0.9901248,0.0001383254,0.00001785563,0.0001887833,0.00004366695,0.00005303764,0.0002381858,0.0000219694,0.0009895567,0.007670701],"study_design_scores_gemma":[0.00331569,0.00005065019,0.974699,0.0003669494,0.00002653487,0.00007624132,0.00001801275,0.0005243119,0.01554709,0.00006304146,0.005142555,0.0001698935],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880583,0.000348038,0.000001968148,0.007532307,0.00066999,0.0003921087,0.00002537681,0.00003424331,0.002937612],"genre_scores_gemma":[0.9633456,0.0003222809,0.00008000049,0.03520867,0.00006931605,0.0000128966,0.00001796203,0.00001598438,0.0009273315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2877395,"threshold_uncertainty_score":0.6777461,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248226877","doi":"10.2165/00151234-201006080-00020","title":"Hypoglycaemia exacts extra costs in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Services Management and Policy","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Economics; Public health; Medicine; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04313908097705882,"gpt":0.4395245993307293,"spread":0.3963855183536705,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006317768,0.0002913163,0.0005191718,0.0001963716,0.0002872765,0.00001836844,0.0005678672,0.0001377491,0.00401318],"category_scores_gemma":[0.00005849163,0.0002895292,0.00006716,0.0001592749,0.00001616526,0.0002904852,0.0002089524,0.001512022,0.001421827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001569194,"about_ca_system_score_gemma":0.003118796,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9832561,"about_ca_topic_score_gemma":0.9983512,"domain_scores_codex":[0.9971006,0.0001989495,0.001044268,0.0003910918,0.0001303871,0.001134715],"domain_scores_gemma":[0.9977999,0.0007944071,0.0003588068,0.0004927956,0.00003799363,0.0005160713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003587252,0.00002600113,0.8810119,0.000164406,0.00002480956,0.00001538695,0.0005818334,0.00001976545,0.000174111,0.001802524,0.1030575,0.01308591],"study_design_scores_gemma":[0.001869124,0.0000051378,0.3027313,0.00001730444,0.00001351066,5.534913e-7,0.0005466657,0.0007624369,0.00002322259,0.0001375197,0.6936241,0.0002690363],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8908222,0.00003455599,0.000002286124,0.03278129,0.005621874,0.001019869,0.00004744708,0.00006255373,0.06960791],"genre_scores_gemma":[0.8127857,0.000187349,0.0001864144,0.1823084,0.0006493511,0.0001594418,0.00003235869,0.00005259176,0.003638388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5905667,"threshold_uncertainty_score":0.9999557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235510047","doi":"10.2165/00151234-200705250-00014","title":"Pregnancy during isotretinoin use “frequent” in Canada","year":2007,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Isotretinoin; Pregnancy; Medicine; Public health; Obstetrics; Dermatology; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01239208681679069,"gpt":0.2815139910462808,"spread":0.2691219042294902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000144265,0.0002415673,0.0002968314,0.00007683301,0.00004905815,0.00002893404,0.0002262512,0.00007237867,0.00008840546],"category_scores_gemma":[0.00005106923,0.0002610141,0.0001184144,0.0000557553,0.00002134192,0.00001619379,0.00008474591,0.0001494454,0.0000111063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003142406,"about_ca_system_score_gemma":0.000622137,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5255551,"about_ca_topic_score_gemma":0.9340745,"domain_scores_codex":[0.998451,0.00003621684,0.000481763,0.000422291,0.00007435906,0.000534393],"domain_scores_gemma":[0.9992766,0.00003437918,0.0001364714,0.0003394429,0.00002408558,0.0001889779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001243199,0.00005385767,0.8555475,0.00003921488,0.0001019959,0.000004314639,0.00008260076,0.0003842761,0.1231624,0.0001660398,0.01421801,0.006115367],"study_design_scores_gemma":[0.002526751,0.00001199499,0.1926282,0.00001677856,0.00002489731,0.00001338285,0.0001101584,0.00001726169,0.08414002,0.0000186568,0.720042,0.0004498956],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895985,0.001675062,0.00004924757,0.0002750481,0.006780791,0.0002665604,0.00004941992,0.00001169827,0.001293638],"genre_scores_gemma":[0.9901678,0.002165288,0.0003072291,0.003134964,0.002222388,0.00002522329,0.00004580685,0.0000506484,0.001880642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.705824,"threshold_uncertainty_score":0.9999842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233544818","doi":"10.1007/bf03276687","title":"Healthcare administration costs huge in the US vs Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Quality and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Health administration; Quality of Life Research; Health care; Administration (probate law); Health economics; Business; Public health; Public administration; Public economics; Medicine; Economics; Political science; Economic growth; Nursing; Law","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.08790370956313619,"gpt":0.4825034681273154,"spread":0.3945997585641792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001975137,0.0002266762,0.0004014143,0.00008147142,0.0005426969,0.00002357441,0.0003549144,0.0001121301,0.0004514925],"category_scores_gemma":[0.0001561248,0.0001871884,0.00007007473,0.0001448765,0.00001964336,0.0001522497,0.00004635665,0.0008108076,0.0001805605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001699103,"about_ca_system_score_gemma":0.003033412,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7569471,"about_ca_topic_score_gemma":0.9809833,"domain_scores_codex":[0.9957178,0.001901804,0.001068757,0.0003546869,0.0001930307,0.0007639207],"domain_scores_gemma":[0.9980849,0.000852256,0.0003110429,0.0004574238,0.00005297018,0.0002414026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001216737,0.0001433233,0.6295786,0.0005662144,0.00005959837,0.00005481499,0.003305718,0.00004365695,0.000006003475,0.124338,0.2337878,0.007994516],"study_design_scores_gemma":[0.001222284,0.00003860282,0.06361523,0.00002393235,0.00001379404,0.000002012248,0.005277525,0.00004725462,0.00001661787,0.0004262054,0.9291102,0.0002063882],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6688233,0.0001629371,0.00002831829,0.3053086,0.002811133,0.002193059,0.00009608572,0.00004614873,0.02053042],"genre_scores_gemma":[0.7089224,0.0002250431,0.00007094707,0.2895116,0.0001146761,0.0002554997,0.00003879025,0.00001905853,0.0008419332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6953223,"threshold_uncertainty_score":0.7633321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234596508","doi":"10.2165/00151234-200504830-00043","title":"Trastuzumab to be provided free in British Columbia","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04803241967852492,"gpt":0.3218295073160283,"spread":0.2737970876375034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007451035,0.0003278127,0.001142033,0.0003209485,0.0001383813,0.000773762,0.001109912,0.0001597233,0.004778081],"category_scores_gemma":[0.0001852336,0.0006319182,0.000343343,0.000254376,0.00003986606,0.0007322566,0.0003584079,0.0004515028,0.002749017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009177133,"about_ca_system_score_gemma":0.0001072062,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03459939,"about_ca_topic_score_gemma":0.2510622,"domain_scores_codex":[0.9959764,0.0000300533,0.001827677,0.0009996908,0.00004105676,0.001125069],"domain_scores_gemma":[0.998058,0.000150959,0.0003827513,0.0007096353,0.00002131356,0.0006773129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000648445,0.0008642672,0.5451635,0.0000662215,0.0003390643,0.00003139869,0.001343261,0.003090165,0.00009155388,0.01824784,0.3912028,0.03949503],"study_design_scores_gemma":[0.003991352,0.00004618854,0.04250498,0.000008603437,0.00001553144,0.0000137263,0.00006512801,0.005641128,0.00005498777,0.009622189,0.9371986,0.0008376246],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8955699,0.0006333328,0.0001065584,0.07243314,0.0009650977,0.001058155,0.00135441,0.0001192713,0.02776014],"genre_scores_gemma":[0.8397127,0.0004543648,0.00159178,0.1530633,0.0004950543,0.0002276368,0.00003175647,0.0001121602,0.004311257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5459958,"threshold_uncertainty_score":0.9996132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4250440661","doi":"10.1007/s40274-017-4035-3","title":"High-risk screening for lung cancer cost effective in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Lung cancer; Public health; Health economics; Business; Actuarial science; Medicine; Risk analysis (engineering); Environmental health; Oncology; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0202402612847341,"gpt":0.3765268415913038,"spread":0.3562865803065697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001396049,0.0002412172,0.0006213299,0.00006020855,0.0002263629,0.00006038082,0.0001909957,0.00003853987,0.0001459837],"category_scores_gemma":[0.00005339648,0.0002109721,0.0001502143,0.0000194803,0.00002201817,0.0001594685,0.00006734533,0.0001764807,0.000004023995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003507602,"about_ca_system_score_gemma":0.0007503132,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9732419,"about_ca_topic_score_gemma":0.9739589,"domain_scores_codex":[0.998787,0.00002288848,0.000325491,0.0003934877,0.00007901789,0.0003920886],"domain_scores_gemma":[0.9987028,0.000316041,0.0003224518,0.000416708,0.00003906183,0.0002029853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002170572,0.00004849054,0.8939745,0.00006955392,0.0005540951,0.00001940522,0.00004771547,0.0007709255,0.0000108928,0.00004143043,0.0133112,0.09093474],"study_design_scores_gemma":[0.0136938,0.00004620835,0.9491844,0.0001013602,0.000612649,0.000001949069,0.00003737698,0.007576652,0.002473197,0.00002211364,0.02599491,0.0002554035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9739612,0.0007308513,0.000181437,0.01862104,0.001743234,0.003862694,0.0005286785,0.00001957021,0.0003513242],"genre_scores_gemma":[0.9869977,0.001330181,0.000803589,0.007259194,0.0003042929,0.00299783,0.0000331078,0.00004576287,0.0002282936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09067933,"threshold_uncertainty_score":0.9172258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4237991971","doi":"10.1007/bf03276098","title":"Outpatient treatment with LMWHs cost saving for DVT in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Business; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03430035471702979,"gpt":0.3348682017506567,"spread":0.3005678470336269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008118985,0.0002000759,0.0006175322,0.00007881878,0.00006331466,0.0000145203,0.00001433782,0.00002169839,0.00002392578],"category_scores_gemma":[0.00002930645,0.0001560343,0.0001215018,0.0000567321,0.00001283468,0.0000464536,0.000009640593,0.0000590795,0.00001020079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001862587,"about_ca_system_score_gemma":0.0007649763,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.313485,"about_ca_topic_score_gemma":0.6164379,"domain_scores_codex":[0.9990239,0.00002281557,0.0003287003,0.0002581786,0.00007453474,0.0002918613],"domain_scores_gemma":[0.9993094,0.0002408051,0.000101361,0.0001732229,0.00003796782,0.0001373006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002434397,0.00004727699,0.984952,0.00002442666,0.0002965344,0.000008232597,0.000315681,0.001142525,0.00004362659,0.0001071172,0.005918566,0.006900552],"study_design_scores_gemma":[0.009835024,0.0002047385,0.06428748,0.0000240617,0.0002233546,0.00005394753,0.0008892025,0.0002433287,0.001261612,0.0000115304,0.9226584,0.0003072929],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751508,0.0003989668,0.0000888547,0.001271059,0.0005407419,0.001123279,0.00007075995,0.00002414614,0.02133143],"genre_scores_gemma":[0.9940715,0.0002003074,0.0005701618,0.004055914,0.00005413925,0.0001564199,0.0000178661,0.00002786232,0.0008458325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9206645,"threshold_uncertainty_score":0.6910865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235534330","doi":"10.2165/00151234-200404500-00049","title":"Medical association welcomes Canadian govt funding initiative","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Association (psychology); Public health; Health economics; Business; Medicine; Psychology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.07055426202808049,"gpt":0.4584102226975196,"spread":0.3878559606694391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001809301,0.0003785311,0.0008360932,0.0004015138,0.001206119,0.0000399748,0.0005731906,0.0005627068,0.009643057],"category_scores_gemma":[0.000662485,0.0003691533,0.000257508,0.0002078265,0.00003598268,0.0005523554,0.0001921811,0.001679689,0.006829515],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01421037,"about_ca_system_score_gemma":0.01112246,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1603518,"about_ca_topic_score_gemma":0.4731455,"domain_scores_codex":[0.9957085,0.000377068,0.001320936,0.0004938876,0.0004385303,0.001661029],"domain_scores_gemma":[0.9959626,0.001521891,0.0006043799,0.0003534749,0.0001662513,0.001391378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002647097,0.00004172618,0.7438143,0.00008733678,0.0002251869,0.00003949164,0.001976219,0.00002394724,0.000009134476,0.01012202,0.2402909,0.003343277],"study_design_scores_gemma":[0.00463905,0.00003117973,0.1253703,0.00004175893,0.00007367787,0.000003770273,0.001137861,0.00003411832,0.00003364237,0.003226759,0.8649113,0.0004966348],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2081607,0.0003104664,0.0001167102,0.5333005,0.009642037,0.001406632,0.0003136086,0.000351604,0.2463978],"genre_scores_gemma":[0.3511682,0.001429189,0.0003949361,0.6415395,0.00132594,0.0002106221,0.0001042956,0.00008693016,0.003740482],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.6246204,"threshold_uncertainty_score":0.999876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235063194","doi":"10.1007/s40274-018-5025-9","title":"Midostaurin a cost-effective option for AML in Canada","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Midostaurin; Medicine; Public health; Leukemia; Internal medicine; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01564952570542606,"gpt":0.3515246722911419,"spread":0.3358751465857158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002082364,0.0001829774,0.0002319728,0.00007958582,0.00007765482,0.00002119736,0.000228594,0.00006929933,0.00005314162],"category_scores_gemma":[0.00008132515,0.0001974817,0.00009566398,0.00005605513,0.00005693924,0.000008576113,0.00009889287,0.0001137052,0.00004052632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007451126,"about_ca_system_score_gemma":0.0007574577,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2975213,"about_ca_topic_score_gemma":0.8759844,"domain_scores_codex":[0.9987234,0.00006405804,0.0002980304,0.000420381,0.00007112199,0.0004229846],"domain_scores_gemma":[0.9993674,0.00006664364,0.0000854953,0.0002615842,0.00007769636,0.0001412303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001537359,0.000209348,0.06803233,0.00009079507,0.0003011306,0.00001608854,0.0002450242,0.0007296511,0.6453416,0.0001613544,0.1821292,0.101206],"study_design_scores_gemma":[0.002494281,0.0001334812,0.003784081,0.000004930431,0.0000107661,0.000004431695,0.00007651265,0.001577425,0.4971408,0.00002461626,0.4944752,0.0002734529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946501,0.0001051247,0.00047318,0.001420307,0.0006630648,0.001903827,0.0001442305,0.000007617872,0.0006324972],"genre_scores_gemma":[0.9936356,0.00006760216,0.0003765041,0.003709195,0.0004598027,0.0008396576,0.0001225085,0.00004094787,0.0007481754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5784631,"threshold_uncertainty_score":0.8053071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210414282","doi":"10.1007/s40274-021-08159-x","title":"Active TB screening may be cost saving in high-incidence Inuit communities in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Incidence (geometry); Public health; Environmental health; Medicine; Demography; Sociology; Mathematics; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05181062410397016,"gpt":0.3554184749846189,"spread":0.3036078508806487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003423835,0.0003250579,0.0008327799,0.0003033094,0.0001005656,0.00006865675,0.0003515138,0.00008557588,0.001479766],"category_scores_gemma":[0.0001739378,0.0003572604,0.0001253989,0.0003728608,0.00006021673,0.0002343198,0.0003940225,0.001101116,0.00002497991],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004120359,"about_ca_system_score_gemma":0.00424714,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9541823,"about_ca_topic_score_gemma":0.9932023,"domain_scores_codex":[0.9975445,0.0001971044,0.000760046,0.0004092194,0.0003041258,0.0007850123],"domain_scores_gemma":[0.9980374,0.0008844018,0.0001391333,0.000530224,0.0001054451,0.0003034127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004345952,0.0001935392,0.9456674,0.0001171902,0.0001698532,0.001265045,0.001888355,0.001887886,0.005683687,0.00008976283,0.003218872,0.03938385],"study_design_scores_gemma":[0.01651559,0.0001032341,0.6767738,0.0005734835,0.0001804639,0.0002279992,0.04279073,0.01056645,0.1937343,0.00005465344,0.05702857,0.001450734],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792843,0.0003139421,0.00000533677,0.01824163,0.0003074427,0.0005310772,0.0001940592,0.00002458109,0.001097625],"genre_scores_gemma":[0.9856279,0.001185031,0.0002227542,0.01194186,0.0001080311,0.0000767435,0.0001420702,0.00005094097,0.0006445936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2688936,"threshold_uncertainty_score":0.9998879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243610834","doi":"10.1007/s40274-013-0885-5","title":"Economic impact of introducing dimethyl fumarate into Canada","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chemical Synthesis and Reactions","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Dimethyl fumarate; Quality of Life Research; Chemistry; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.007919565342639892,"gpt":0.2946075268403729,"spread":0.2866879614977331,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007388123,0.0002742465,0.0005384237,0.00004867185,0.00007416215,0.00005134111,0.0003416452,0.00007577621,0.01404115],"category_scores_gemma":[0.00003597937,0.0002327177,0.0003441653,0.00003088526,0.00004167974,0.0002298019,0.0001093695,0.0002265975,0.0002294233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001805786,"about_ca_system_score_gemma":0.0006879452,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8862477,"about_ca_topic_score_gemma":0.1436864,"domain_scores_codex":[0.9985743,0.00001331226,0.0006371833,0.0003620871,0.00005922705,0.0003539522],"domain_scores_gemma":[0.9986699,0.0003057237,0.0003212737,0.0004205601,0.00002983857,0.0002526822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002563253,0.0000686452,0.1056939,0.00007456953,0.0007957164,0.000001290911,0.0001136443,0.003226042,0.7554606,0.00004400215,0.1084343,0.02606158],"study_design_scores_gemma":[0.00170537,0.00001553446,0.01480536,0.00002265889,0.0001736746,0.00001092325,0.0002280378,0.007606709,0.8771041,0.0006376814,0.09670747,0.0009824546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880756,0.00009865269,0.000003963685,0.002519947,0.0003804498,0.00009723284,0.00006506796,0.0000332448,0.008725855],"genre_scores_gemma":[0.9973449,0.0001303355,0.0002009939,0.0005475871,0.0002979118,0.00003518302,0.0000261948,0.00004088643,0.001376035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7425613,"threshold_uncertainty_score":0.9868602,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247730375","doi":"10.2165/00151234-201005990-00027","title":"Seek and Treat to kick off in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02739122967409572,"gpt":0.4196170269675339,"spread":0.3922257972934382,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003886661,0.0002781317,0.0006559251,0.0001865541,0.0002712535,0.00001477239,0.0003008436,0.0001160889,0.001640296],"category_scores_gemma":[0.0000820311,0.0002597866,0.00005960958,0.0001093627,0.00001896752,0.0001918296,0.0002326313,0.001020336,0.0003893269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00161376,"about_ca_system_score_gemma":0.005043783,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8926222,"about_ca_topic_score_gemma":0.995798,"domain_scores_codex":[0.9976261,0.0001285398,0.0008562264,0.0004314919,0.0001029752,0.0008546294],"domain_scores_gemma":[0.9979354,0.0008497426,0.0001720442,0.0003848227,0.00003993006,0.0006181218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004747907,0.00001445309,0.7972825,0.0000702066,0.00001512387,0.00001349031,0.0006982297,0.000006103119,0.0003484074,0.0003260946,0.1807017,0.02047624],"study_design_scores_gemma":[0.00161213,0.00001212929,0.3492311,0.000006256173,0.00001532185,0.000002247687,0.0004955476,0.0000743417,0.00005884257,0.0001381353,0.6481071,0.0002469133],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8848836,0.0001115548,0.000002745865,0.093056,0.002650218,0.0008390172,0.0001281568,0.00004426931,0.0182844],"genre_scores_gemma":[0.5424278,0.0004465555,0.0005497193,0.4507596,0.0003570748,0.0001256988,0.00002118777,0.00005828275,0.005253994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4674054,"threshold_uncertainty_score":0.9999855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4213146317","doi":"10.1007/bf03279452","title":"Effect of H2-antagonist Rx-to-OTC switch in the US, UK and Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Public health","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0110706169974401,"gpt":0.3012965126590904,"spread":0.2902258956616503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004550835,0.0002207503,0.0005825798,0.0001096115,0.00004669643,0.00002052009,0.0001837728,0.00004248388,0.0002474521],"category_scores_gemma":[0.0000873884,0.000149304,0.00009201234,0.000102422,0.00002886452,0.00004593773,0.00005028825,0.0002296028,0.00004382079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001463673,"about_ca_system_score_gemma":0.00006960966,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3016642,"about_ca_topic_score_gemma":0.1562682,"domain_scores_codex":[0.9988022,0.0001110548,0.000394654,0.0002506791,0.0001254041,0.0003159651],"domain_scores_gemma":[0.9985835,0.0008349424,0.00009671519,0.0003029395,0.0000135713,0.0001683291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002587114,0.00006835938,0.9320974,0.0002133671,0.000129272,0.00009972101,0.0003338119,0.00007017126,0.003155924,0.00003528569,0.0447499,0.01878808],"study_design_scores_gemma":[0.03963581,0.002121053,0.2922616,0.0002035843,0.001470144,0.0005338623,0.0004838866,0.005021974,0.08605773,0.00009524653,0.5705103,0.001604874],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837249,0.0004027084,0.000003786491,0.01093627,0.0003422379,0.0007369959,0.0000246497,0.00001208436,0.003816359],"genre_scores_gemma":[0.974882,0.0003297594,0.00006864431,0.0240071,0.0001219272,0.00004066562,0.000005246175,0.00002399716,0.0005206316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6398358,"threshold_uncertainty_score":0.8591277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4238629410","doi":"10.1007/s40274-014-1539-y","title":"Salmeterol/fluticasone cost effective in asthma in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Salmeterol; Fluticasone; Asthma; Quality of Life Research; Medicine; Public health; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.009858979572449989,"gpt":0.304686657059757,"spread":0.294827677487307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002174533,0.0002516761,0.000657753,0.0001899708,0.00002917134,0.00001635508,0.000140663,0.00005220279,0.000226306],"category_scores_gemma":[0.0001039629,0.0002273335,0.0001124947,0.0001182879,0.00003167172,0.0001058659,0.00006011015,0.0002954428,0.00009773835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001166833,"about_ca_system_score_gemma":0.0005898121,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3451341,"about_ca_topic_score_gemma":0.7426943,"domain_scores_codex":[0.9984532,0.0001320758,0.0004840865,0.0003699005,0.0001103742,0.0004503564],"domain_scores_gemma":[0.9989365,0.0003490722,0.000104491,0.0002621255,0.00002018273,0.000327668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001958904,0.0001041558,0.9096971,0.0000436492,0.00003451083,0.00008001859,0.00004085809,0.0003058473,0.0002802477,0.00002770899,0.002415212,0.08677482],"study_design_scores_gemma":[0.005522414,0.00006850186,0.8481185,0.00003348126,0.00003120524,0.00001078516,0.0001027107,0.003437148,0.0007982812,0.00002190675,0.141613,0.0002420215],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934278,0.000221265,0.00002868064,0.002839952,0.0004678973,0.001175099,0.00002986337,0.00002342299,0.001785984],"genre_scores_gemma":[0.9731629,0.00004056182,0.00007129471,0.02626728,0.0001225907,0.0001805511,0.00001646823,0.00003611086,0.0001021967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3975602,"threshold_uncertainty_score":0.927039,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255485385","doi":"10.2165/00151234-201206550-00035","title":"Expansion of Canadian insulin pump programme cost saving","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Insulin pump; Economics; Public health; Medicine; Diabetes mellitus; Endocrinology; Nursing; Type 1 diabetes","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04300395360708603,"gpt":0.3388789495350784,"spread":0.2958749959279924,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002218916,0.0002274389,0.0005716372,0.0003871017,0.00008113805,0.00001915398,0.0001390885,0.0001183523,0.0006248017],"category_scores_gemma":[0.0001141884,0.0002021312,0.0002313049,0.0001603445,0.00005886222,0.0002145486,0.00004619816,0.0002383752,0.0001648459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002156568,"about_ca_system_score_gemma":0.0002718893,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03909009,"about_ca_topic_score_gemma":0.005360879,"domain_scores_codex":[0.9982654,0.00002969916,0.0005854052,0.0002233544,0.0001213382,0.0007748412],"domain_scores_gemma":[0.9983728,0.0001103715,0.0001130319,0.0002802067,0.00008672641,0.001036865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003093047,0.0003280699,0.897568,0.0001111793,0.000242673,0.00001394801,0.0008161769,0.000006339515,0.003975895,0.001266939,0.003129872,0.09223161],"study_design_scores_gemma":[0.0131204,0.0002989384,0.1223163,0.00009666862,0.0006129078,0.00006396373,0.0005927717,0.0006460435,0.006360742,0.0001085052,0.855118,0.0006646963],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791235,0.0005380773,0.00002382957,0.005906631,0.001061794,0.0007848248,0.00005848931,0.00004352603,0.01245936],"genre_scores_gemma":[0.9878085,0.0004263642,0.0007557979,0.01017781,0.0002534922,0.00006373932,0.00007034135,0.00003580521,0.0004081096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8519882,"threshold_uncertainty_score":0.9673087,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239369968","doi":"10.1007/s40274-021-7452-2","title":"Early-phase trials used in reimbursement submissions in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Reimbursement; Quality of Life Research; Phase (matter); Actuarial science; Business; Medicine; Public health; Political science; Chemistry; Nursing; Law; Health care","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.4574671061897916,"gpt":0.5305500618397155,"spread":0.07308295564992395,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01509523,0.0004106663,0.003008119,0.0005665975,0.0001090004,0.0001292397,0.0004890999,0.0001376394,0.003437077],"category_scores_gemma":[0.003863385,0.000537737,0.0003109174,0.0003369896,0.0000264811,0.0005786234,0.0001415115,0.0004642359,0.0008035045],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005520732,"about_ca_system_score_gemma":0.003143323,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8064763,"about_ca_topic_score_gemma":0.8930808,"domain_scores_codex":[0.9875153,0.00103639,0.009421878,0.001021313,0.0001158645,0.0008892731],"domain_scores_gemma":[0.9932108,0.002929605,0.002551518,0.0007889349,0.00004458929,0.0004745538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000517025,0.0003851154,0.9400185,0.0001186791,0.0001693921,0.00006292979,0.001082574,0.001315187,0.0000550228,0.009768365,0.04605856,0.0009140141],"study_design_scores_gemma":[0.03234948,0.00007871577,0.4503852,0.0001826913,0.00005629937,0.00001512808,0.004943734,0.01383904,0.0006174787,0.0114334,0.4838285,0.00227033],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8872727,0.001435896,0.0001122464,0.1049165,0.002164996,0.001060724,0.0006631323,0.00002895821,0.002344925],"genre_scores_gemma":[0.9295157,0.0006743515,0.001116236,0.06656715,0.0002887052,0.0003233941,0.0001309471,0.00008290047,0.001300686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4896333,"threshold_uncertainty_score":0.9999745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243068281","doi":"10.2165/00151234-201106200-00034","title":"Azacitidine reimbursed in Quebec, Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Azacitidine; Public health; Medicine; Chemistry; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02704849171701705,"gpt":0.2930696187665474,"spread":0.2660211270495303,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009807554,0.0002650339,0.0005255563,0.0001590863,0.00003828848,0.00001302464,0.0001335125,0.0000488158,0.001947868],"category_scores_gemma":[0.00001579974,0.0002354363,0.0001043068,0.00009531094,0.00002284748,0.0001310598,0.0000466216,0.0001769408,0.0002022451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008786842,"about_ca_system_score_gemma":0.0008792556,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7944252,"about_ca_topic_score_gemma":0.9681824,"domain_scores_codex":[0.9986348,0.00002582164,0.0005031966,0.000330598,0.0001034477,0.0004021039],"domain_scores_gemma":[0.9992974,0.0000556056,0.000102232,0.0002617076,0.00002452731,0.000258567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001807076,0.0002401505,0.9023219,0.00002904973,0.0002977794,0.0003896366,0.000848487,0.00000384507,0.0001592593,0.0002874459,0.08876354,0.006478207],"study_design_scores_gemma":[0.0133316,0.0000364139,0.420508,0.0000509688,0.0002864214,0.00003081972,0.0005993664,0.0002700882,0.01468815,0.0001933419,0.5492197,0.0007851849],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9428337,0.0001529496,0.00001047507,0.02056045,0.0006459464,0.0005791237,0.00001674778,0.00006143874,0.03513923],"genre_scores_gemma":[0.9090979,0.0001759392,0.00116431,0.01409007,0.00008755502,0.00007641184,0.00007305993,0.00004881694,0.07518597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4818139,"threshold_uncertainty_score":0.9989645,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234833161","doi":"10.2165/00151234-201206550-00032","title":"Benefits of Crestor card continue in Canada","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05884608121265341,"gpt":0.3099594378561737,"spread":0.2511133566435203,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005016869,0.000198003,0.0007048735,0.0002330739,0.00003400218,0.00001464488,0.0002974439,0.00005096669,0.0003115365],"category_scores_gemma":[0.00005459926,0.000243516,0.0001154551,0.0001116705,0.0000173738,0.000287394,0.0001037046,0.0001632721,0.0001867158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009137443,"about_ca_system_score_gemma":0.0001917591,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9666397,"about_ca_topic_score_gemma":0.8924363,"domain_scores_codex":[0.9979702,0.0000239385,0.001080435,0.000269235,0.00003161849,0.0006245594],"domain_scores_gemma":[0.9988763,0.0001113561,0.0004403604,0.0003190168,0.00001345497,0.0002395245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001155285,0.00005357762,0.886384,0.00005372892,0.00006306016,7.177609e-7,0.0003305163,0.0004675611,0.000002015246,0.0989913,0.008175067,0.005466936],"study_design_scores_gemma":[0.001058109,0.00001061447,0.4851962,0.000007834765,0.000008785708,0.000001034253,0.0001333299,0.0002582365,0.0001645747,0.0006241341,0.5122238,0.000313246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9659951,0.003044351,0.00003729793,0.01144835,0.002018454,0.0003812537,0.0004255856,0.00001545419,0.01663416],"genre_scores_gemma":[0.9872535,0.0005991471,0.0002030958,0.01120052,0.0001728709,0.00004260915,0.00001153412,0.00002994234,0.00048681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5040488,"threshold_uncertainty_score":0.9930293,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253046517","doi":"10.1007/s40274-016-2925-4","title":"ASCO endorses Cancer Care Ontario treatment guidelines","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Cancer; Family medicine; Nursing; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2915147588622064,"gpt":0.5500505289812848,"spread":0.2585357701190784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002010125,0.0003481677,0.0006541226,0.0001126858,0.00008082423,0.0000357102,0.0001504609,0.00007546262,0.006183044],"category_scores_gemma":[0.0003919893,0.0002214782,0.0003633932,0.00004831245,0.00004126387,0.0003626104,0.00007743499,0.000122642,0.0005625635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002479989,"about_ca_system_score_gemma":0.001018315,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1038988,"about_ca_topic_score_gemma":0.2109125,"domain_scores_codex":[0.997423,0.00005036625,0.001450303,0.0005230021,0.0001546149,0.0003987032],"domain_scores_gemma":[0.9978566,0.0006930178,0.000413326,0.0004587265,0.0002753551,0.000302954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002872484,0.000109751,0.6467002,0.00001580787,0.0004125938,0.00001587525,0.0004515731,0.00002261275,0.002636388,0.00003423869,0.03148692,0.3178267],"study_design_scores_gemma":[0.01116658,0.0002337773,0.04686761,0.00004222203,0.0007836569,0.00002008068,0.0004448756,0.00003747976,0.007877328,0.00006006223,0.9321426,0.0003237264],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8790273,0.0005849848,0.0001576253,0.1151702,0.001954607,0.0009698055,0.0001617404,0.00012343,0.001850275],"genre_scores_gemma":[0.8645529,0.006486024,0.007878542,0.09314945,0.002179496,0.0004858356,0.0001642797,0.0001487152,0.02495471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9006557,"threshold_uncertainty_score":0.9947255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236444549","doi":"10.1007/bf03275733","title":"Resource use low among Canadian women with psychiatric disorders","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Psychiatry; Resource (disambiguation); Public health; Resource use; Psychology; Medicine; Computer science; Economics; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01426372169150721,"gpt":0.3104943048282689,"spread":0.2962305831367617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007000357,0.0002748033,0.0004056646,0.0002545129,0.0009578509,0.0003080383,0.0003996143,0.000119293,0.001344794],"category_scores_gemma":[0.0001455763,0.0002589306,0.000107982,0.0002850349,0.0001842372,0.0006359612,0.0000205789,0.0002522001,0.0001175644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001110009,"about_ca_system_score_gemma":0.001367516,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5584221,"about_ca_topic_score_gemma":0.9159666,"domain_scores_codex":[0.9972188,0.0002651172,0.0004281361,0.0004165374,0.0001792506,0.001492087],"domain_scores_gemma":[0.9976447,0.0003464729,0.0001674258,0.000315509,0.00003059103,0.001495312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001947641,0.0000325162,0.9650695,0.00002215084,0.00005041539,0.000003515858,0.003521873,0.0001438335,9.372157e-8,0.0104461,0.01904386,0.001646645],"study_design_scores_gemma":[0.0008074346,0.00001646745,0.1694618,0.000004911437,0.00001823149,5.29334e-7,0.004963446,0.00001844426,0.000001353741,0.0003995759,0.8239658,0.0003418948],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9179072,0.0000828097,0.00001484938,0.02176496,0.001006606,0.0006122704,0.00003653878,0.00009225187,0.05848252],"genre_scores_gemma":[0.9297081,0.0005879546,0.0003615685,0.06106484,0.0001728482,0.00009758168,0.000006576331,0.00006000796,0.007940499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.804922,"threshold_uncertainty_score":0.9999863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230561190","doi":"10.2165/00151234-201006090-00003","title":"Grade A NACI recommendation for rotavirus vaccine in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Rotavirus vaccine; Rotavirus; Virology; Medicine; Public health; Virus; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03283751322459917,"gpt":0.3880215328744271,"spread":0.3551840196498279,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003328691,0.0001642754,0.0005099541,0.0001211422,0.00004106871,0.00001264797,0.0001373204,0.00004894521,0.0007372115],"category_scores_gemma":[0.0002299954,0.000153865,0.0001095998,0.00004883138,0.00001141545,0.0001161293,0.00004891952,0.0004326884,0.00002661782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004560367,"about_ca_system_score_gemma":0.0004773108,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6103785,"about_ca_topic_score_gemma":0.9538934,"domain_scores_codex":[0.9985552,0.00004631218,0.0005288367,0.0002909613,0.00004872299,0.0005299086],"domain_scores_gemma":[0.9992654,0.0001202198,0.000107288,0.0001841337,0.00003127864,0.0002916669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005063586,0.00007550728,0.8722718,0.00004061368,0.00007030707,0.00001472166,0.00001702173,0.00002361723,0.0120584,0.00006461409,0.07366192,0.04119512],"study_design_scores_gemma":[0.01234795,0.0001989658,0.3651683,0.00001171009,0.00004182625,0.00007451831,0.00008192028,0.009941461,0.001858054,0.0003077658,0.6097069,0.0002606468],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9152787,0.00001864531,0.0001017195,0.08254968,0.000934615,0.0007277204,0.0001021431,0.00001788364,0.0002689079],"genre_scores_gemma":[0.9643418,0.0001887027,0.00203018,0.03253813,0.0002367284,0.000180744,0.0001926482,0.00002881427,0.0002622612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.536045,"threshold_uncertainty_score":0.8071949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230978315","doi":"10.1007/bf03280259","title":"Prescription drug spending in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medical prescription; Drug; Prescription drug; Health economics; Public health; Business; Public economics; Economics; Medicine; Pharmacology; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05390289870986077,"gpt":0.3151178097705197,"spread":0.261214911060659,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004339785,0.0002111129,0.0004922011,0.0002973586,0.00007108346,0.00005989342,0.0003275678,0.00003528446,0.00111488],"category_scores_gemma":[0.00003091113,0.0002689402,0.00009443269,0.0001483431,0.00001091246,0.0003809279,0.0001009495,0.0002141765,0.0006630325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001934339,"about_ca_system_score_gemma":0.000151592,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9853306,"about_ca_topic_score_gemma":0.977707,"domain_scores_codex":[0.9979572,0.00002548381,0.0009601651,0.0004515439,0.00003077566,0.0005747863],"domain_scores_gemma":[0.999146,0.00006446011,0.0002925796,0.0003051474,0.000006570931,0.0001852058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001633927,0.00003622326,0.9166603,0.00002820604,0.00004072812,0.00002271732,0.000214221,0.0007066851,0.000003461115,0.06184039,0.0159159,0.004514817],"study_design_scores_gemma":[0.001082882,0.000005350944,0.177642,0.000006584286,0.000004514111,0.000003376679,0.0001742022,0.00408923,0.00002940989,0.00580214,0.8108118,0.0003485449],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9016051,0.0005763036,0.0001884059,0.04157542,0.002364068,0.000509635,0.0001011439,0.00004380333,0.0530361],"genre_scores_gemma":[0.9761699,0.001302967,0.0001560864,0.01933634,0.0001243357,0.00004982926,0.00001614727,0.00003235679,0.002812078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7948958,"threshold_uncertainty_score":0.9999763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234530602","doi":"10.1007/s40274-013-0236-6","title":"Pharmacists could save Ontario's public health system big $","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Health economics; Business; Environmental health; Medicine; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.160703422337893,"gpt":0.3402437597583849,"spread":0.1795403374204919,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001220404,0.0005072348,0.001236598,0.0005734433,0.0003233376,0.0004250393,0.0007510739,0.0001329355,0.003012318],"category_scores_gemma":[0.00003670089,0.0005858679,0.0003764345,0.0002058135,0.00005698025,0.0007361164,0.0002616254,0.0005070479,0.0113961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00315664,"about_ca_system_score_gemma":0.000359523,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2632222,"about_ca_topic_score_gemma":0.02000058,"domain_scores_codex":[0.9955101,0.00008181457,0.002024084,0.0009301907,0.00007200708,0.001381797],"domain_scores_gemma":[0.9970786,0.0001105022,0.00104513,0.0007562051,0.00005564746,0.0009539397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002106142,0.0004302309,0.2181738,0.0006364533,0.0008653603,0.00001636425,0.003352506,0.0001040702,0.00001102428,0.48367,0.2140148,0.07870436],"study_design_scores_gemma":[0.001904108,0.00004990615,0.01452477,0.00001059163,0.00001015577,0.00001317194,0.0002010294,0.001779202,0.00001648356,0.00247749,0.9783953,0.0006177715],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3210753,0.00269552,0.004813602,0.4545726,0.01395941,0.005417476,0.000844361,0.0009966549,0.195625],"genre_scores_gemma":[0.9084018,0.0005902944,0.0006679677,0.08075554,0.0004692549,0.000456931,0.00006400957,0.00009684122,0.008497384],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7643805,"threshold_uncertainty_score":0.9996593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239998127","doi":"10.1007/s40274-018-4899-x","title":"Cost of living kidney donor care substantial in Canada","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Public health; Business; Medicine; Environmental health; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02206480715044049,"gpt":0.32596959214293,"spread":0.3039047849924895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006318012,0.0001122148,0.0002728231,0.000112592,0.00002648914,0.000007811872,0.0000810418,0.0000280116,0.001284284],"category_scores_gemma":[0.000047564,0.00011323,0.00005044497,0.00007919747,0.00002505187,0.0000892922,0.00001323461,0.00009966074,0.00003167116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004788329,"about_ca_system_score_gemma":0.001175117,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4964953,"about_ca_topic_score_gemma":0.8728859,"domain_scores_codex":[0.9991918,0.00002058353,0.0003681653,0.0001637228,0.00008255708,0.0001731293],"domain_scores_gemma":[0.9994395,0.0001137609,0.0001031159,0.0001217926,0.0000642337,0.0001575347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009366015,0.00002783681,0.9901159,0.0000997487,0.00005031973,0.00000957041,0.001468164,0.00001455562,0.001719146,0.00006163275,0.002673094,0.003666346],"study_design_scores_gemma":[0.004119208,0.00006055568,0.9167368,0.0001613013,0.0001604494,0.0000158004,0.001765859,0.001208717,0.04408242,0.000006395421,0.03138363,0.0002988649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920158,0.00004807677,0.00005197254,0.002854429,0.0007977618,0.0003280894,0.0001224505,0.00001541978,0.003765983],"genre_scores_gemma":[0.9893563,0.000107945,0.0001938761,0.01003045,0.0001217866,0.000006626949,0.00003759194,0.00001838881,0.0001270699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3763906,"threshold_uncertainty_score":0.9996287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234163504","doi":"10.1007/bf03267040","title":"Canada's health system restricts drug access","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Drug; Health economics; Business; Environmental health; Medicine; Pharmacology; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05204346335349221,"gpt":0.3448193823364696,"spread":0.2927759189829774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000665827,0.0005016398,0.001335094,0.0002641439,0.0003167504,0.0003502079,0.001252054,0.00008824339,0.004383829],"category_scores_gemma":[0.00002546983,0.0006038803,0.0003054431,0.0002364215,0.00005194408,0.0006392839,0.0001730997,0.0004371787,0.002723781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001784977,"about_ca_system_score_gemma":0.0008503885,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7155321,"about_ca_topic_score_gemma":0.2292048,"domain_scores_codex":[0.9958774,0.00005752132,0.001960968,0.000918762,0.00005492444,0.001130411],"domain_scores_gemma":[0.9975066,0.0001773008,0.0007220483,0.0007108476,0.00002012435,0.0008631233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008212475,0.0001587901,0.06761753,0.0002051036,0.0004521559,0.00002485337,0.0002474831,0.002719649,0.000002340215,0.1208974,0.7862963,0.02129626],"study_design_scores_gemma":[0.001682808,0.00001361357,0.009542703,0.00001200996,0.00001498981,0.00001230636,0.00003428415,0.006622483,0.00004373651,0.00184345,0.9795212,0.0006563948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4669187,0.005010622,0.00007522527,0.2279935,0.00457841,0.001554012,0.00409961,0.000385328,0.2893846],"genre_scores_gemma":[0.8421465,0.002585006,0.0001544022,0.1482098,0.000527664,0.00008519354,0.00006616832,0.0001122645,0.006113095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4863273,"threshold_uncertainty_score":0.9996412,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4237553453","doi":"10.2165/00151234-201006130-00020","title":"Insulin initiation: cost-effective options in Canada?","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Insulin; Economics; Public health; Medicine; Internal medicine; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02967356865642003,"gpt":0.3619676933345514,"spread":0.3322941246781314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001388913,0.0001980915,0.0003516047,0.0001635123,0.00004883079,0.00003879331,0.000149646,0.00003989232,0.001883935],"category_scores_gemma":[0.00005778592,0.0002044922,0.00008914097,0.0001189741,0.0000329192,0.0002276024,0.00007581431,0.0004032036,0.0001513188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001062764,"about_ca_system_score_gemma":0.001501577,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3765341,"about_ca_topic_score_gemma":0.8829099,"domain_scores_codex":[0.998864,0.00002946369,0.0003868032,0.0003035036,0.0001035218,0.0003126953],"domain_scores_gemma":[0.9991722,0.0001663033,0.0001102575,0.0003059422,0.00003396475,0.0002113442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002972783,0.0004946243,0.8538457,0.0002016348,0.0004897183,0.0002448813,0.000278305,0.00170103,0.001270277,0.01361881,0.05236557,0.07519219],"study_design_scores_gemma":[0.006312756,0.00002251541,0.777649,0.00001380602,0.0001457382,0.00001117539,0.0003447698,0.003361951,0.0003319302,0.0003817797,0.2111249,0.0002996817],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9485924,0.0000829815,0.00002237519,0.01785512,0.001438896,0.002279232,0.0000680628,0.00005956413,0.02960132],"genre_scores_gemma":[0.98355,0.0001630645,0.0002003357,0.01496796,0.0002003315,0.000488023,0.00009048443,0.00002792083,0.0003119215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5063758,"threshold_uncertainty_score":0.9990285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230202677","doi":"10.1007/s40274-014-1349-2","title":"Guanfacine's stimulating results in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Animal Nutrition and Physiology","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Guanfacine; Quality of Life Research; Economics; Medicine; Public health; Anesthesia; Clonidine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02343419157195818,"gpt":0.2764279969109024,"spread":0.2529938053389442,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001269595,0.0001238202,0.0002402312,0.00000944706,0.0000610685,0.00001734838,0.0001851901,0.00003065447,0.0003813934],"category_scores_gemma":[0.00003925614,0.00005581323,0.00005520662,0.00006722062,0.0000105011,0.00007237976,0.00004850418,0.0001179152,0.0000556011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001297016,"about_ca_system_score_gemma":0.00002935429,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7727603,"about_ca_topic_score_gemma":0.9411417,"domain_scores_codex":[0.9990358,0.00006867896,0.0003491485,0.0002427465,0.00004593177,0.000257665],"domain_scores_gemma":[0.9993225,0.0004279192,0.00009567016,0.00004254555,0.00001326623,0.00009810828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003442458,0.0001048227,0.6913594,0.00001274073,0.00003109924,0.000007288553,0.00007094826,0.002300223,0.1181813,0.001049286,0.03533501,0.1512036],"study_design_scores_gemma":[0.001150588,0.0000690959,0.7623329,0.000004955383,0.000004685919,0.000001412882,0.0001169342,0.006257662,0.0003474921,0.0004756191,0.2289769,0.0002617186],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821793,0.00001525926,8.738128e-7,0.01427933,0.0002197986,0.0001019649,0.00007195422,0.00002118457,0.003110333],"genre_scores_gemma":[0.9818609,0.00002324771,0.00005369051,0.01772646,0.0001599065,0.000006187446,0.00005862179,9.859914e-7,0.0001099743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1936419,"threshold_uncertainty_score":0.4175991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249070868","doi":"10.2165/00151234-200404670-00014","title":"Additional pertussis booster warranted among Canadian teens","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Booster (rocketry); Quality of Life Research; Medicine; Pediatrics; Public health","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01650590057423232,"gpt":0.3268944248113092,"spread":0.3103885242370769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001196426,0.0002380824,0.0003446758,0.0003472285,0.0001680209,0.00007035175,0.0001542356,0.00007224289,0.1160241],"category_scores_gemma":[0.0000678299,0.0002141265,0.0002534511,0.0001036265,0.00009493547,0.0002482237,0.00004935299,0.0002961457,0.002014536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006179718,"about_ca_system_score_gemma":0.000688787,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0271009,"about_ca_topic_score_gemma":0.04740267,"domain_scores_codex":[0.9984165,0.00002870356,0.000346395,0.000373549,0.0001861092,0.0006487577],"domain_scores_gemma":[0.9986776,0.0001088129,0.00006785082,0.0002132831,0.00009573919,0.0008367012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001268032,0.0002470586,0.6518231,0.00004133382,0.0005709112,0.0002535155,0.0002052869,0.00001382299,0.0003807758,0.0001315657,0.3359479,0.01025793],"study_design_scores_gemma":[0.004711812,0.00009468803,0.5934196,0.00003878698,0.0001186081,0.00004895217,0.0001602797,0.0001411296,0.0009607603,0.0001681334,0.3998563,0.0002809715],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8884819,0.00005040843,0.00004695507,0.04209509,0.0004314565,0.000981528,0.004801328,0.0001031416,0.06300818],"genre_scores_gemma":[0.9414473,0.00006441806,0.0003974608,0.04592772,0.0002655349,0.0001966099,0.002377069,0.00005205667,0.009271851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1140096,"threshold_uncertainty_score":0.9987625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230081928","doi":"10.1007/bf03280326","title":"Sumatriptan nearly always cost saving for Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Sumatriptan; Business; Economics; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02529442409879043,"gpt":0.328677761408315,"spread":0.3033833373095245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003064701,0.0003447316,0.00118293,0.000102819,0.0001549236,0.0000754221,0.0002015724,0.00008954947,0.0005399779],"category_scores_gemma":[0.0001298768,0.0003098546,0.0006335367,0.0001265821,0.00003554299,0.0001629882,0.00004389181,0.0002175102,0.00007634822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006131273,"about_ca_system_score_gemma":0.0006898371,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1262865,"about_ca_topic_score_gemma":0.1096396,"domain_scores_codex":[0.998045,0.00004042324,0.0006370849,0.0004325948,0.0001855122,0.0006594392],"domain_scores_gemma":[0.9979669,0.0008769025,0.0001560977,0.000385141,0.00009153959,0.000523433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004910229,0.00008452399,0.897668,0.00006792491,0.0004665376,0.0002491691,0.00009535757,0.00007985373,0.0003355431,0.002091397,0.06940248,0.02896816],"study_design_scores_gemma":[0.003911439,0.00003749561,0.08230335,0.000009544751,0.000214393,0.0001573176,0.0001255299,0.0004242098,0.0002071904,0.00001627944,0.9122657,0.0003275949],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8739871,0.0007101508,0.0003999823,0.06138228,0.002739773,0.002635269,0.0001297552,0.0002153481,0.05780028],"genre_scores_gemma":[0.8720954,0.000891444,0.001471824,0.09600922,0.001024508,0.0002378007,0.0001594624,0.000156264,0.02795405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8428631,"threshold_uncertainty_score":0.9999353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253917067","doi":"10.1007/s40274-014-1042-5","title":"Ticagrelor good value for money in ACS in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ticagrelor; Value (mathematics); Value for money; Quality of Life Research; Business; Economics; Medicine; Mathematics; Internal medicine; Acute coronary syndrome; Public health; Public economics; Statistics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0117280074185926,"gpt":0.290141817118358,"spread":0.2784138096997654,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002876716,0.0001987151,0.0006345141,0.0001048184,0.00002766132,0.00001355761,0.0001425853,0.00004907852,0.00006346469],"category_scores_gemma":[0.00005333981,0.0001892289,0.0002445685,0.00007137132,0.00001599297,0.00008642318,0.00002897921,0.0001559778,0.00002376967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005074575,"about_ca_system_score_gemma":0.0005201279,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2808717,"about_ca_topic_score_gemma":0.390591,"domain_scores_codex":[0.998737,0.00005675137,0.0004268729,0.0003081152,0.00009560065,0.0003756456],"domain_scores_gemma":[0.9992437,0.0002073091,0.00007006279,0.0002771924,0.00001753319,0.0001841417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006023374,0.0001712809,0.9266942,0.0001445651,0.000508683,0.00004894923,0.0001307327,0.002416885,0.0004051893,0.001406602,0.004101918,0.06336869],"study_design_scores_gemma":[0.0294641,0.0001179729,0.4141339,0.0000708218,0.0004348431,0.00003578273,0.0003320659,0.01648569,0.004577639,0.0007056763,0.5328401,0.0008014166],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920817,0.0005518994,0.0001576132,0.00451884,0.000410262,0.0006860757,0.00003288895,0.00002077863,0.001539959],"genre_scores_gemma":[0.9795956,0.0003828492,0.0002642653,0.01924035,0.0001419447,0.00008195615,0.00003348219,0.00003817573,0.0002213855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5287381,"threshold_uncertainty_score":0.771653,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233304861","doi":"10.1007/bf03276005","title":"Opioid analgesics underused for neuropathic pain in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Medicine; Opioid; Pain management; Quality of Life Research; Anesthesia; Intensive care medicine; Public health; Nursing; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02495193501392969,"gpt":0.3040613647155284,"spread":0.2791094297015987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001229603,0.0002419466,0.000477609,0.0001527504,0.00005560402,0.00002709991,0.0001633508,0.00003994997,0.0001547881],"category_scores_gemma":[0.0003730207,0.0002431284,0.0001365935,0.0001243883,0.0000145618,0.00008518988,0.00002723633,0.0002060516,0.00001919962],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007273087,"about_ca_system_score_gemma":0.0009659486,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1449225,"about_ca_topic_score_gemma":0.4664726,"domain_scores_codex":[0.9983874,0.0001968393,0.0004944094,0.0003548243,0.0001002777,0.0004662405],"domain_scores_gemma":[0.9987321,0.0006145839,0.0001237932,0.0003030187,0.00002570189,0.0002008165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008788104,0.0000834407,0.9515765,0.000150778,0.0001059678,0.00005086147,0.00006694946,0.0003465917,0.0001883161,0.001806739,0.03385725,0.01167873],"study_design_scores_gemma":[0.01011695,0.0001175836,0.1540608,0.00003380386,0.0002159005,0.000002816068,0.0004361896,0.03162427,0.0009571494,0.001488749,0.8002726,0.0006731134],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9764938,0.0003480889,0.003958311,0.01164913,0.001318282,0.001821921,0.00003077613,0.00006806577,0.004311674],"genre_scores_gemma":[0.9177734,0.0003548767,0.001452639,0.07886349,0.00009862867,0.00009659834,0.00003598628,0.00006254071,0.001261901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7975157,"threshold_uncertainty_score":0.9914486,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231037796","doi":"10.1007/s40274-017-4376-y","title":"Addition of palbociclib to letrozole not cost effective in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Palbociclib; Letrozole; Quality of Life Research; Medicine; Public health; Internal medicine; Cancer; Breast cancer","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01963600267837518,"gpt":0.3615838674096126,"spread":0.3419478647312374,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001104532,0.0001900393,0.0005701603,0.0001000009,0.0000714569,0.00001699693,0.0002417933,0.00003094761,0.0003246357],"category_scores_gemma":[0.00008340993,0.0001892854,0.00008961616,0.00003560469,0.00004048243,0.0002117025,0.00008662949,0.0001795272,0.00003959797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001423251,"about_ca_system_score_gemma":0.0004864682,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5895726,"about_ca_topic_score_gemma":0.7535965,"domain_scores_codex":[0.9989159,0.00002538141,0.0003756115,0.0002788842,0.0001053706,0.0002988321],"domain_scores_gemma":[0.9988448,0.0001598699,0.0002838511,0.0004735424,0.00004452803,0.0001934219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001253333,0.00007896795,0.6835611,0.00008062492,0.0002123552,0.00003578457,0.0002753883,0.0008094824,0.01158824,0.000107608,0.003343477,0.2986537],"study_design_scores_gemma":[0.006480814,0.00006160827,0.8320439,0.00006214498,0.00005433329,0.000008953841,0.0001681372,0.0003414923,0.05411708,0.00006421653,0.1063479,0.0002494036],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829192,0.00005336511,0.00008355602,0.01310287,0.0006915862,0.001432209,0.0002652065,0.00001584771,0.001436195],"genre_scores_gemma":[0.9835968,0.00003411637,0.0004347242,0.01527345,0.0001307472,0.0002618617,0.00001975174,0.00003326539,0.0002152645],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2984043,"threshold_uncertainty_score":0.7718836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233484819","doi":"10.2165/00151234-201106250-00011","title":"Dabigatran etexilate highly cost effective in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Dabigatran; Quality of Life Research; Computer science; Medicine; Public health; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.06022181616515183,"gpt":0.3435310277547639,"spread":0.2833092115896121,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001872992,0.0002695853,0.0006265769,0.0001820916,0.00004708056,0.00001649299,0.0001577957,0.00004967238,0.0008018872],"category_scores_gemma":[0.00003194936,0.0002471563,0.0001856542,0.0001341139,0.00002425892,0.0001989115,0.00007146046,0.0002126109,0.0001824492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008887601,"about_ca_system_score_gemma":0.0003699322,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6199163,"about_ca_topic_score_gemma":0.6552809,"domain_scores_codex":[0.9985101,0.00005422223,0.0005643697,0.000351833,0.0001168122,0.000402644],"domain_scores_gemma":[0.9991295,0.0001769822,0.0001636388,0.0002749254,0.00002600155,0.0002289857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000273978,0.00001127925,0.976256,0.00003498378,0.0001805823,0.00006774663,0.0002117892,0.00006911287,0.0003167836,0.000459324,0.00261904,0.01949937],"study_design_scores_gemma":[0.005004079,0.00003905854,0.8791682,0.00001419192,0.0001638683,0.000007130671,0.0001487327,0.0006700731,0.004250584,0.000143905,0.1100683,0.0003218424],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9685833,0.0000865409,0.00003139567,0.007237815,0.001410939,0.002177582,0.00002163984,0.00006545895,0.02038528],"genre_scores_gemma":[0.9870618,0.0001274053,0.0003434647,0.01091687,0.0002266764,0.00003924466,0.00002520286,0.00004151227,0.001217809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1074493,"threshold_uncertainty_score":0.9999981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4238317182","doi":"10.1007/bf03269190","title":"Which TB screening method for immigrants to Canada?","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Immigration; Quality of Life Research; Public health; Political science; Medicine; Law; Nursing","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05501685564534359,"gpt":0.4369387218149321,"spread":0.3819218661695885,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008287648,0.0002554567,0.000802386,0.0001756629,0.0001229314,0.00002283532,0.0002544923,0.0000784014,0.0003398727],"category_scores_gemma":[0.0007613308,0.0002266666,0.0002025364,0.0001641433,0.000009670106,0.00007352663,0.00009247971,0.0002697278,0.0000779671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000335,"about_ca_system_score_gemma":0.0004715555,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6995147,"about_ca_topic_score_gemma":0.8534567,"domain_scores_codex":[0.9978079,0.0001039631,0.0005741679,0.0004989529,0.0001247137,0.0008902982],"domain_scores_gemma":[0.9976817,0.0009073278,0.00009594343,0.0003560396,0.0001266135,0.000832402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009867824,0.00006505855,0.3029622,0.00004793811,0.00055167,0.00002457677,0.00009227177,0.0008552744,0.002995611,0.0001483408,0.6027108,0.08855945],"study_design_scores_gemma":[0.003116644,0.0001143821,0.07607692,0.00001220733,0.0001114882,0.00006478754,0.0001307503,0.01508682,0.001190465,0.00006482288,0.903757,0.000273688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.3163718,0.0002113867,0.02700859,0.6496154,0.000773667,0.001748523,0.000155972,0.00008657616,0.004028083],"genre_scores_gemma":[0.2669908,0.0004953124,0.08826824,0.6374157,0.0008970441,0.0003782763,0.0001343901,0.0001126508,0.005307565],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3010461,"threshold_uncertainty_score":0.9243196,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4249836732","doi":"10.1007/s40274-013-0696-8","title":"Quebec's decision to cap price of PPIs \"misguided\"","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Law and economics; Public health; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.21739077562157,"gpt":0.4757159449988448,"spread":0.2583251693772749,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005603177,0.0004555192,0.002000513,0.0007251404,0.0001638809,0.0001849715,0.0009321725,0.0001871248,0.006840914],"category_scores_gemma":[0.002019352,0.0005570721,0.0004082898,0.0002643423,0.0000631886,0.00121722,0.0002474184,0.0002549368,0.02497347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001083497,"about_ca_system_score_gemma":0.0002477393,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05899775,"about_ca_topic_score_gemma":0.003669344,"domain_scores_codex":[0.9911749,0.0001823698,0.006752351,0.0009737309,0.0001201912,0.0007964432],"domain_scores_gemma":[0.993469,0.001857235,0.002771191,0.001069735,0.0001531537,0.0006796696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000438794,0.0002668612,0.1971547,0.0002772573,0.0003304652,0.000001291147,0.002334584,0.001862618,0.000167005,0.05557263,0.7361913,0.00579747],"study_design_scores_gemma":[0.003672525,0.0001260841,0.2253632,0.0000917943,0.00003618485,0.000008326322,0.001179153,0.007260081,0.0004614241,0.02558277,0.7346618,0.001556654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8889152,0.0009064153,0.006723896,0.0882471,0.002350482,0.002334507,0.0003336417,0.0001184099,0.01007039],"genre_scores_gemma":[0.7504438,0.0004302809,0.03223724,0.2056055,0.000783405,0.0007146988,0.00006042854,0.000207242,0.009517445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1384714,"threshold_uncertainty_score":0.9996881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249484723","doi":"10.2165/00151234-200504770-00015","title":"Osteoporosis treatment suboptimal in Canada","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Osteoporosis; Medicine; Public health; Internal medicine; Pathology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01839375753447195,"gpt":0.3015883457465346,"spread":0.2831945882120626,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005015557,0.0001940991,0.0003745748,0.0001059178,0.00003185136,0.00001491137,0.00006498198,0.00003260264,0.002915616],"category_scores_gemma":[0.000009456349,0.0001745876,0.0001138884,0.00006627103,0.00001137386,0.00010689,0.00001782206,0.0001021762,0.0002760947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002162916,"about_ca_system_score_gemma":0.00107416,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7565565,"about_ca_topic_score_gemma":0.9348718,"domain_scores_codex":[0.9989788,0.00001640525,0.0003735809,0.0002579383,0.0000705631,0.0003026924],"domain_scores_gemma":[0.9994359,0.00005251492,0.00007010088,0.0002024497,0.00001317137,0.0002258713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001999684,0.0001956884,0.9186418,0.000008035717,0.0001054062,0.00002076424,0.0001798637,0.001361546,0.0001186583,0.00006311428,0.02432712,0.05477802],"study_design_scores_gemma":[0.01350582,0.0001008759,0.169209,0.000005014263,0.0001259364,0.00003302579,0.0007417413,0.004709578,0.001047001,0.000010867,0.8101894,0.0003216892],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9364496,0.0001638748,0.000006415652,0.04434483,0.000494249,0.0003497761,0.00002051115,0.00003554255,0.01813524],"genre_scores_gemma":[0.9480841,0.0002557195,0.0007021575,0.04707188,0.0001383723,0.00003703707,0.00003151967,0.00002705834,0.003652113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7858623,"threshold_uncertainty_score":0.9979959,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239596802","doi":"10.1007/s40274-013-0638-5","title":"A quarter of US antibiotic prescriptions are not indicated","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medical prescription; Quality of Life Research; Antibiotics; Health economics; Public health; Medicine; Pharmacology; Microbiology; History; Nursing; Biology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01408837776899442,"gpt":0.2748794903544489,"spread":0.2607911125854545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008155909,0.0002173557,0.0004990142,0.000138752,0.0001057915,0.00002274985,0.0003272815,0.0001690894,0.002807525],"category_scores_gemma":[0.00001852153,0.0001827642,0.0001926276,0.00007105026,0.0001717094,0.0001919236,0.00007484972,0.0002419958,0.003593482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003745108,"about_ca_system_score_gemma":0.00004309273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001073952,"about_ca_topic_score_gemma":0.0001206854,"domain_scores_codex":[0.9986884,0.00008320174,0.0005386467,0.0003045023,0.00002165915,0.0003635757],"domain_scores_gemma":[0.9991003,0.00009663005,0.0003738656,0.0003327284,0.00005043325,0.00004603693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007234327,0.0004055993,0.4905909,0.00008759391,0.0007854347,0.000003033776,0.0003613655,0.00001788107,0.4058565,0.0004869285,0.09989265,0.001439777],"study_design_scores_gemma":[0.003383376,0.0000829352,0.7273639,0.00005406968,0.0002145628,0.00001890986,0.0005692503,0.00006804032,0.2170852,0.0001409319,0.05052102,0.0004977957],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915481,0.000591562,0.00004452976,0.004094876,0.001023928,0.000425505,0.00008329737,0.00006815978,0.002120086],"genre_scores_gemma":[0.9911474,0.0002165665,0.0001063271,0.004350568,0.00002798278,0.000007519644,0.00003877485,0.00002295149,0.004081914],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.236773,"threshold_uncertainty_score":0.998104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4256330601","doi":"10.1007/bf03280626","title":"Canada to respect `Cipro' patent","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Mathematics; Medicine; Public health","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1448462339186643,"gpt":0.2821749050451156,"spread":0.1373286711264513,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001839239,0.0002719702,0.000317592,0.0001747099,0.0001979243,0.0002382711,0.000462362,0.00003850699,0.003386666],"category_scores_gemma":[0.00009574504,0.0002344294,0.0001120051,0.0002065774,0.00001257361,0.0005226678,0.0002320056,0.0001703529,0.00333954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002332318,"about_ca_system_score_gemma":0.000132413,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7426332,"about_ca_topic_score_gemma":0.5751686,"domain_scores_codex":[0.9985278,0.00001070115,0.0004189354,0.0003827052,0.0001466185,0.0005132271],"domain_scores_gemma":[0.999401,0.00006898259,0.0001291399,0.0002681651,0.00007424808,0.00005840987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003303234,0.00009166782,0.1559895,0.00004563952,0.0001383338,0.00008732155,0.00007280208,0.001221836,0.0004158806,0.001433257,0.8222144,0.01795908],"study_design_scores_gemma":[0.0006896012,0.000007296675,0.006624285,0.000007613135,0.00003405123,0.000003426341,0.0000563435,0.002379385,0.0002398173,0.0002135071,0.9893774,0.0003672263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8655216,0.00005228511,0.00007233776,0.03512126,0.002770503,0.000566597,0.00001347367,0.000120522,0.09576142],"genre_scores_gemma":[0.7910458,0.00003462201,0.00004314531,0.2009378,0.0009459681,0.00003152549,0.00001954016,0.00004290731,0.006898627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1674646,"threshold_uncertainty_score":0.9975244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}